The Spontaneously Diabetic Torii-Lepr fa (SDT-fa/fa) rat, a new model of obese type 2 diabetes, shows obesity, hyperglycemia, and hyperlipidemia from 6 weeks of age. Diabetic complications such as nephropathy and cataract are observed with aging; however, blood pressure change with age has not previously been examined. In this study, blood pressure was periodically measured and the change was investigated. Blood pressure in male SDT-fa/fa rats was elevated at 8, 16, and 24 weeks of age, whereas the heart rate was not changed. In addition to hyperglycemia, hyperlipidemia, and proteinuria, hyperleptinemia and increased urine angiotensinogen were observed in SDT-fa/fa rats. Blood pressure and heart rate in the male original SDT (SDT-+/+) rat did not significantly change. In conclusion, the SDT-fa/fa rat is a promising model, showing significant hypertension with diabetes mellitus. Key words: blood pressure, diabetes, SDT-fa/fa rat (Received 8 February 2010 / Accepted 21 March 2010 Address corresponding: T. Ohta, Japan Tobacco Inc., Central Pharmaceutical Research Institute, 1-1 Murasaki-cho, Takatsuki, Osaka 569-1125, Japan Cardiovascular diseases are major causes of death in persons with diabetes, and many factors, including hypertension, contribute to this high prevalence of cardiovascular disease. Hypertension, a common comorbid condition in dysmetabolic syndrome, often occurs in patients with type 2 diabetes, and vigorous control of blood pressure decreases the rate of cardiovascular events in such patients. Control of high blood pressure represents the most important intervention for such patients, limiting cardiovascular events more effectively than tight glycemic control [1, 2, 15] . Moreover, metabolic syndrome is defined worldwide as a lifestyle disease, and is described as a clustering of multiple metabolic abnormalities and cardiovascular risk factors, including hypertension, obesity, hyperlipidemia, and insulin resistance [3] . From these and other perspectives, it is an important to examine the relation between glycolipid abnormalities and blood pressure.
Cardiovascular diseases are major causes of death in persons with diabetes, and many factors, including hypertension, contribute to this high prevalence of cardiovascular disease. Hypertension, a common comorbid condition in dysmetabolic syndrome, often occurs in patients with type 2 diabetes, and vigorous control of blood pressure decreases the rate of cardiovascular events in such patients. Control of high blood pressure represents the most important intervention for such patients, limiting cardiovascular events more effectively than tight glycemic control [1, 2, 15] . Moreover, metabolic syndrome is defined worldwide as a lifestyle disease, and is described as a clustering of multiple metabolic abnormalities and cardiovascular risk factors, including hypertension, obesity, hyperlipidemia, and insulin resistance [3] . From these and other perspectives, it is an important to examine the relation between glycolipid abnormalities and blood pressure.
The Spontaneously Diabetic Torii-Lepr
rat is a new model of obese type 2 diabetes, and was established by introducing the fa gene of the Zuckerfatty rat into the SDT rat genome [8] . SDT-fa/fa rats exhibit hyperphagia and obesity immediately after weaning, and diabetes and its complications are found at a younger age in SDT-fa/fa rats than in SDT-+/+ rats [4, 9, 10, 12] . However, blood pressure in SDT-fa/fa rats has not yet been examined. In the present study, we periodically investigated the blood pressure of male -Note-SDT-fa/fa rats. Male SDT-fa/fa rats and original SDT (SDT-+/+) rats aged 8, 16, and 24 weeks of age from our colonies were used in this study. Age-matched Sprague-Dawley (SD) rats were used as control animals; the SD rats were purchased from CLEA Japan, Inc. (Tokyo, Japan). The rats were housed in suspended bracket cages in a climatecontrolled room with a temperature of 23 ± 3°C, humidity of 55 ± 15%, and a 12-h lighting cycle. A basal diet (CRF-1, Oriental Yeast Co., Ltd., Tokyo, Japan) and water were provided ad libitum. All the experiments were performed in accordance with the in-house Manual of Animal Experiments of Japan Tobacco. Body weight and biochemical parameters such as serum glucose, insulin, leptin, triglyceride (TG), and total cholesterol (TC) levels were measured at 8, 16, and 24 weeks of age in the non-fasting state. Blood samples were collected from the tail vein of the rats. Serum glucose, TG, and TC levels were measured using commercial kits (Roche Diagnostics, Basel, Switzerland) and an automatic analyzer (Hitachi 7180; Hitachi, Tokyo, Japan). Serum insulin or leptin levels were measured with a rat insulin-or leptin enzyme-linked immunosorbent assay (ELISA) kit (Morinaga Institute of Biological Science, Yokohama, Japan). Renal-related parameters, such as blood urea nitrogen (BUN) level, urine volume, urinary protein, creatinine clearance, and urine angiotensinogen level were also evaluated at 8, 16, and 24 weeks of age. Serum BUN level was measured using a commercial kit (Roche Diagnostics) and an automatic analyzer. The urine angiotensinogen level was measured with an enzyme immuno-assay (EIA) kit (Immuno-Biological Laboratories, Fujioka, Japan). Creatinine clearance (ml/h·g) was calculated by dividing the 8-h urinary excretion of creatinine by the serum creatinine concentration and body weight. Systolic blood pressure (SBP) and heart rate in the conscious state were measured at 8, 16, and 24 weeks of age by the indirect tail cuff method using a Softron BP-98A (Softron, Tokyo, Japan). The blood pressure and heart rate were measured between 13:00 h and 16:00 h. Five measurements were made for each rat and averaged. The results are expressed as the mean ± SD. Statistical analysis of differences between mean values was performed using an F-test, followed by Student's t-test or Aspin-Welch's t-test. Differences were considered significant at P<0.05.
Body weight, serum parameters, except for the leptin level, and renal-related parameters except for the urine angiotensinogen level were determined in previous studies [4, 8] . The results of the present study are shown in Table 1 . In this study, the leptin and urine angiotensinogen levels, systolic blood pressure, and heart rate were determined as novel findings. These novel findings are shown in Figs. 1 and 2 . SDT-fa/fa rats showed obesity, hyperglycemia and hyperlipidemia during the experimental period in agreement with previous reports [4, 9] . Obesity and hyperinsulinemia in SDT-fa/fa rats were observed only at 8 weeks of age. Body weights at 16 and 24 weeks of age and serum insulin level at 24 weeks of age of the SDT-fa/fa rats were lower than those of the SD rats because of the severe progression of diabetes mellitus. Body weights and serum insulin levels of the SDT-+/+ rats decreased after 16 weeks of age (Table 1) . Also, the increase of renal-related parameters such as BUN, urine volume, and urinary protein, was observed in SDT-fa/fa rats, similar to results reported in previous studies (Table 1) [4, 10] . In addition to these changes, increases of serum leptin and urine angiotensinogen levels were shown by the SDT-fa/fa rats (Fig. 1) . Furthermore, an increase of SBP was observed during the experimental period (Fig. 2) . Hyperglycemia in the SDT-+/+ rats was observed from 16 weeks of age (Table 1) , but there was no significant change in blood pressure (Fig. 2) . Hypertension with diabetes mellitus is considered to be caused by factors such as obesity, hyperinsulinemia, hyperleptinemia, activation of the Renin-Angiotensin System (RAS), lesion of the vascular endothelium, and other factors/causes [2, 14, 17] . Activation of the sympathic nervous system due to obesity or hyperleptinemia, and sodium retention due to hyperinsulinemia lead to hypertension. As mentioned above, obesity, hyperinsulinemia and hyperleptinemia in SDTfa/fa rats are considered to partially induce increase of blood pressure. Furthermore, RAS in SDT-fa/fa rats might be activated, since the urine angiotensinogen levels were elevated (Fig. 1) . Correlation between SBP and body weight, insulin, leptin, or urine angiotensinogen was examined. In SDT-fa/fa rats at 8 or 16 weeks of age, a strong positive correlation was observed between SBP and body weight (8 weeks of age: R 2 =0.6189, 16 weeks of age: R 2 =0.6442). Furthermore, a strong positive correlation was observed between SBP and the leptin level in SDT-fa/fa rats at 24 weeks of age (R 2 =0.6543). As an increase of blood pressure is caused by the activation of RAS [14] , the RAS in SDT-fa/fa rats should be examined in a future study. Renal-related parameters showed abnormal levels, so hypertension in SDT-fa/fa rats is possibly caused by renal lesion. It is well known that renal lesion leads to hypertension [14] .
Changes in blood pressure with diabetes mellitus have been examined in other diabetic rat models. In streptozotocin-induced diabetic (STZ) rats, an increase of blood pressure was observed 2 weeks after STZ treatment [7, 16] ; however, STZ rats did not show hypertension in other [6, 11] . The presence of hypertension in STZ rats is controversial. In Zucker diabetic-fatty (ZDF) rats, changes in blood pressure were not observed at 7 weeks of age, but increases were observed after 13 weeks of age [13, 20] . ZDF rats are considered to show hypertension with aging. In the present study, SDT-fa/fa rats showed hypertension from 8 weeks of age. An increase of blood pressure in SDT-fa/fa rats was observed at an early age compared with ZDF rats, and this hypertension with diabetes mellitus is an important feature of SDT-fa/fa rats. The SDT-fa/fa rat is a useful model for examining the relations between glycolipid abnormalities and blood pressure excursion. Hypertension in other obese diabetic models has also been reported. . Also, Wistar-fatty rats showed mild hypertension [19] . On the other hand, the Goto-Kakizaki (GK) rat, which is a non-obese type 2 diabetic model, did not show obvious hypertension [5] .
There are some reports of diabetic rats showing a change of heart rate. Male Wistar-fatty rats and STZ rats showed decreases of heart rate, and those changes might have been caused by heart dysfunction [16, 19] . In a further study, it will be necessary to investigate the heart function of SDT-fa/fa rats.
In conclusion, male SDT-fa/fa rats showed an increase Fig. 1 . The serum leptin level (A) and urine angiotensinogen level (B) in SD rats, SDT-+/+ rats, and SDT-fa/fa rats. Data shown as mean ± SD (n=5). *P<0.05, **P<0.01; signifi cant difference from SD rat.
Fig. 2.
Systolic blood pressure (A) and heart rate (B) in SD rats, SDT-+/+ rats, and SDT-fa/fa rats. Data shown as mean ± SD (n=5). *P<0.05, **P<0.01; signifi cant difference from SD rat.
of blood pressure. The SDT-fa/fa rat is a useful model for examining the etiology of hypertension with diabetes mellitus.
